Nutrition intervention's effect on breast cancer patients' bioimpedance phase angle

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the impact of perioperative nutritional interventions on the bioimpedance phase angle in patients with early-stage breast cancer undergoing mastectomy. Participants will be randomly assigned to receive either an oral nutritional supplement or a placebo for a period of 7 days before surgery and 30 days after. The study will measure various parameters, including phase angle, handgrip strength, and other bioimpedance metrics, to determine the effectiveness of the nutritional intervention in improving surgical outcomes. The goal is to assess whether improved nutrition can lead to better recovery and health metrics post-surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female
* Histopathologically confirmed operable breast cancer
* Aged 18 of years and above
* Consented and scheduled for mastectomy

Exclusion Criteria:

* On enteral supplementation prior to the study
* Lactose intolerance
* Pregnant or lactating
* Previous history of gastrectomy or small bowel resection surgery
* Advanced breast cancer staging, presence of pacemaker, decompensated liver disease, end stage renal failure, uncontrolled diabetes, on steroid therapy or complementary traditional medications

Where it's running

• Universiti Malaya Medical Centre
  Petaling Jaya, Kuala Lumpur, Malaysia Recruiting

Study contacts

• Study coordinator: Wai Yin Soo, MD
• Email: waiyin@ummc.edu.my
• Phone: +60 16-365 8711

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Regular exercise to help women with early-stage breast cancer on hormone therapy

  This study tests whether a guided, 16-week exercise program improves quality of life and fitness for women with early-stage breast cancer who are starting adjuvant hormone therapy.

  Recruiting Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares · San Sebastián de los Reyes, Madrid · NCT07893327

• Neoadjuvant Pyrotinib-to-pertuzumab for HER2-positive early breast cancer

  This trial tests whether a two-step neoadjuvant plan with Pyrotinib plus Trastuzumab and Docetaxel followed by Pertuzumab plus Trastuzumab and Docetaxel works better than four cycles of Pertuzumab plus Trastuzumab and Docetaxel in women with HER2-positive early- to locally advanced breast cancer.

  Recruiting Phase 3 Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07797218

• Time‑restricted eating (8‑hour window) during chemotherapy for breast cancer: feasibility and acceptability

  This trial will test whether eating all daily food within an 8‑hour window is practical and acceptable for people starting chemotherapy for stage I–III breast cancer (and some stage IV with oncologist approval).

  Recruiting at 2 sites University of Illinois Chicago · Chicago, Illinois and 1 other locations · NCT07387445

• CPAP-assisted radiotherapy to lower heart and lung dose after breast-conserving surgery

  This tests whether wearing a CPAP breathing device during adjuvant radiotherapy can lower radiation exposure to the heart and lungs for women with early-stage (stage 1–3) breast cancer who had breast‑conserving surgery.

  Recruiting Phase 2/3 Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07373782

• Oncoliq blood test for early detection of breast cancer

  This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.

  Recruiting Oncoliq US Inc · Buenos Aires, Buenos Aires · NCT07331506

• Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients: Geriatric Screening in Action

  This study tests whether using geriatric screening alongside adjuvant CDK4/6 inhibitors helps tailor therapy for adults aged 70 and older with early-stage breast cancer.

  Recruiting at 4 sites Region Jönköping County · Gävle and 4 other locations · NCT07273357

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.